🔥 Monday 19 October 2026 Mon, 19 Oct 2026

Emerald Resources delivered a sharp lift in FY26 profit as its Okvau gold mine generated the cash to fund two new developments. The debt-free, unhedged producer is now moving Dingo Range and Memot from permitting and study work towards construction, while warning that key reserves and timing milestones are still ahead.

International Equities Corporation has returned to a modest annual profit after exiting serviced apartments, but the recovery is fragile. Cash fell sharply, operating cash flow remained negative and the auditor highlighted material uncertainty over the group’s ability to continue as a going concern.

Sunshine Metals is moving Mt Moss toward a planned mid-2027 first gold pour, but its annual report carries a material uncertainty over going concern as the company faces a $10 million deferred payment and roughly $30 million of development spending. The ASX-listed explorer reported a narrower FY2026 loss and $20.57 million in cash after a year of major capital raisings and project expansion.

Metro Mining has reset its 2026 bauxite shipment guidance to 6.0-6.5 million wet metric tonnes after September performance fell below plan. The company is relying on channel repairs, stronger staffing and a drier weather outlook to recover shipments before its February maintenance shutdown.

Finexia Financial Group subsidiary Shared Beginnings has entered voluntary administration after Finexia decided to stop providing further financial support. The move places seven early learning centres across three jurisdictions under administrator control, while the potential financial impact on Finexia remains uncertain.

Tasmea delivered record FY26 earnings and lifted its FY27 guidance, as the WorkPac acquisition reshaped the group and the newly completed Maxim and JPS deals move into the numbers. The opportunity is substantial, but so is the execution task: margin mix, integration and earn-out obligations now matter more than ever.

CZR Resources has reported its strongest Top Camp gold intercept to date, including 0.70 metres at 67.2 grams per tonne, while rock chips point to high-grade iron targets near BHP’s Yarrie operations. The results strengthen the exploration case, but further drilling is needed to establish continuity, thickness and scale.

White Cliff Minerals shareholders have approved an A$8.77 million placement to Hancock Prospecting, giving the private company an expected 13.5% stake and funding a faster exploration campaign at Rae. The capital is aimed at advancing Danvers 1 towards a maiden resource while testing a much larger copper system across Nunavut.

ActivEX has increased the Mt Hogan project’s Inferred Mineral Resource by 30% to 403,000 ounces of contained gold, even after accounting for historical mining. The gain is encouraging, but the estimate remains global and Inferred, with coarse-gold sampling and data-quality gaps still limiting confidence.

Ramsay Health Care’s proposed separation of its 52.79% Ramsay Santé stake has reached a key regulatory milestone, with ASIC registering the Demerger Booklet. Shareholders will vote on the transaction on 24 November, but approval remains only one step in a process that could create two separately traded healthcare exposures.

Critical Minerals Group is seeking up to $2.05 million to begin definitive feasibility work at its Lindfield Vanadium Project, backed by existing shareholders and a new non-executive director. The raise could increase shares on issue by 27% if fully subscribed, with key related-party commitments still requiring approval.

K&S Corporation’s FY2026 annual report confirms a sharp earnings decline, a lower dividend and rising debt as weak demand, margin pressure and the loss of most InfraBuild work weigh on the logistics group. Management expects FY2027 to remain difficult, with no formal earnings guidance provided.

Actinogen Medical says its pivotal XanaMIA Alzheimer’s trial remains on course for topline results in November after the final patient visit was completed. The company also reported $15.9 million in cash, a further $5.3 million from option funding and a projected runway into late 2027 or 2028, assuming future trials are substantially partner-funded.

TG Metals has advanced its Van Uden gold development and Lake Johnston lithium project, including a high-return heap-leach study and a maiden 6.71Mt lithium resource. But the ASX explorer ended September with A$1.523 million in cash, equivalent to just 1.05 quarters of funding at the reported spending rate.

Firebird Metals has produced 99.999% ultra-high-purity manganese sulphate at its Hunan pilot plant and started processing ore from its Western Australian Oakover project. The next test is whether the result can be independently replicated with Australian feedstock before the Perth demonstration plant begins commissioning in 2027.

Acrux has received clearer FDA guidance for Phase III trials of its female testosterone spray, including potential three-year data exclusivity if the product reaches submission. The company also reported positive September-quarter operating cash flow, but that result was largely driven by a $1.977 million R&D tax rebate and Acrux says it is still pursuing funding for the clinical programme.

Asara Resources has reported 21,638 metres of post-MRE drilling at Massan, including a narrow 108.4 g/t gold interval within a broader 14-metre intercept. The results could support further Indicated resource growth, while drilling has begun at the Sogosogoba satellite target ahead of a Kada feasibility study targeted for mid-2027.

Benz Mining has defined a 100-200 metre-wide mineralised system across the first kilometre of the 3km Icon trend, with stacked gold lenses continuing beyond 500 metres vertically. The results add weight to the company’s push for a maiden Glenburgh resource in Q1 2027, while leaving the critical question of true widths and resource scale unresolved.

Clime Capital has begun a valuation and private debt review after KPMG qualified its FY26 audit over $36.2 million of unlisted unit trusts. The company says it has not identified a material adverse change, but any adjustment to asset values, fees or receivables remains unresolved.

NOVONIX has replaced a binding PowerCo supply agreement covering at least 32,000 tonnes of synthetic graphite with a framework that leaves volume and price unresolved. A new offtake deal will only be negotiated after customer qualification and further certification.

Boresight Ltd (ASX: BST) used its first quarter after listing to build inventory, expand its US manufacturing footprint and prepare for a larger military order, despite unaudited revenue of about A$829,000. Cash stood at A$5.39 million with no debt after operating outflows of A$2.28 million.

IODM has posted its strongest-ever September revenue as new university contributions accelerate across the UK and Europe, while its cash position leaves little room for execution missteps. The company ended the quarter with A$747,000 in cash and an estimated 1.2 quarters of funding.

Nyrada has moved its PROTECT-MI heart-attack trial into active recruitment, with four hospitals open and three patients dosed. The biotech also reported supportive US FDA feedback, encouraging preclinical oncology data and AU$13.72 million in cash after a AU$12 million placement.

PolarX has extended high-grade copper mineralisation 60 metres beyond the Caribou Dome resource boundary, with one hole returning 58.5 metres at 2.0% copper. Magnetic data points to another 500 metres of potential western extension, although 13 assay results and further drilling remain outstanding.